COVID-19 UpdatesFree Nebraska Medicine infectious disease experts release open-access book on quarantine and isolation March 27, 2020Vol.46 No.13
COVID-19 UpdatesFree Breast cancer patient featured in The Cancer Letter receives testing for COVID-19, awaits results March 27, 2020Vol.46 No.13
Conversation with The Cancer LetterCOVID-19 & CancerFree Curigliano: Italy’s COVID-19 cases keep rising; maybe next week the curve will flatten6,205 health professionals have tested positive and 44 have died March 27, 2020Vol.46 No.13By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Knudsen, Flomenberg: Eliminate digital health disparities; we don’t want telemedicine to be for the one-percenters March 27, 2020Vol.46 No.13By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Hollander: Fix telehealth infrastructure—or America will be just as unprepared for the next pandemic March 27, 2020Vol.46 No.13By Matthew Bin Han Ong
COVID-19 & CancerFree Class of drugs used to treat CAR T-cell toxicity may reduce COVID-19 deathsTwo randomized trials announced March 24, 2020Vol.46 No.13By Paul Goldberg
Drugs & TargetsFree China accepts sNDA for Zejula in ovarian cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree The U.K. removes Keytruda from Cancer Drug Fund in bladder cancer indication March 20, 2020Vol.46 No.12
